These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14233132)

  • 1. ATTENUATION OF THE MYXOMA VIRUS AND USE OF THE LIVING ATTENUATED VIRUS AS AN IMMUNIZING AGENT FOR MYXOMATOSIS.
    SAITO JK; MCKERCHER DG; CASTRUCCI G
    J Infect Dis; 1964 Dec; 114():417-28. PubMed ID: 14233132
    [No Abstract]   [Full Text] [Related]  

  • 2. EFFECT OF VARYING THE SITE OF INTRADERMAL INOCULATION OF MYXOMA VIRUS ON THE COURSE OF THE DISEASE.
    CHAPPLE PJ; MUIRHEAD-THOMSON RC
    J Comp Pathol; 1964 Jul; 74():366-72. PubMed ID: 14198346
    [No Abstract]   [Full Text] [Related]  

  • 3. Absence of serological evidence of myxoma virus infection in humans exposed during an outbreak of myxomatosis.
    Jackson EW; Dorn CR; Saito JK; McKercher DG
    Nature; 1966 Jul; 211(5046):313-4. PubMed ID: 4381646
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of attenuated strain of myxoma virus].
    Maral R
    C R Acad Hebd Seances Acad Sci D; 1970 Aug; 271(8):737-9. PubMed ID: 4992294
    [No Abstract]   [Full Text] [Related]  

  • 5. AN OUTBREAK OF MYXOMATOSIS CAUSED BY A MODERATELY ATTENUATED STRAIN OF MYXOMA VIRUS.
    CHAPPLE PJ; LEWIS ND
    J Hyg (Lond); 1964 Dec; 62(4):433-41. PubMed ID: 14239923
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination strategies against myxomavirus infections: are we really doing the best?
    Marlier D
    Tijdschr Diergeneeskd; 2010 Mar; 135(5):194-8. PubMed ID: 20334023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHANGES IN THE VIRULENCE AND ANTIGENIC STRUCTURE OF STRAINS OF MYOMA VIRUS RECOVERED FROM AUSTRALIAN WILD RABBITS BETWEEN 1950 AND 1964.
    FENNER F; WOODROOFE GM
    Aust J Exp Biol Med Sci; 1965 Jul; 43():359-70. PubMed ID: 14343496
    [No Abstract]   [Full Text] [Related]  

  • 8. EVOLUTIONARY CHANGES IN MYXOMA VIRUS IN BRITAIN. AN EXAMINATION OF 222 NATURALLY OCCURRING STRAINS OBTAINED FROM 80 COUNTIES DURING THE PERIOD OCTOBER-NOVEMBER 1962.
    FENNER F; CHAPPLE PJ
    J Hyg (Lond); 1965 Jun; 63(2):175-85. PubMed ID: 14308349
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies in the epidemiology of myxomatosis in California. IV. The susceptibility of six leporid species to Californian myxoma virus and the relative infectivity of their tumors for mosquitoes.
    Regnery DC; Marshall ID
    Am J Epidemiol; 1971 Nov; 94(5):508-13. PubMed ID: 5166039
    [No Abstract]   [Full Text] [Related]  

  • 10. [EXPERIMENTAL TRANSMISSION AND CONSERVATION OF THE MYXOMATOUS VIRUS BY CULEX PIPIENS BERBERICUS ROUBAUD].
    RIOUX JA; PECH J; BRES A
    Arch Inst Pasteur Tunis; 1963 Jun; 40():111-4. PubMed ID: 14081592
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.
    Cavadini P; Botti G; Barbieri I; Lavazza A; Capucci L
    Vaccine; 2010 Jul; 28(33):5414-20. PubMed ID: 20598407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis.
    Kerr PJ; Perkins HD; Inglis B; Stagg R; McLaughlin E; Collins SV; Van Leeuwen BH
    Virology; 2004 Jun; 324(1):117-28. PubMed ID: 15183059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bivalent vectored vaccine for control of myxomatosis and rabbit haemorrhagic disease.
    Spibey N; McCabe VJ; Greenwood NM; Jack SC; Sutton D; van der Waart L
    Vet Rec; 2012 Mar; 170(12):309. PubMed ID: 22266680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOME OBSERVATIONS ON THE USE OF THE QUCHTERLONY GEL DIFFUSION TECHNIQUE IN THE STUDY OF MYXOMATOSIS.
    CHAPPLE PJ; BOWEN ET; LEWIS ND
    J Hyg (Lond); 1963 Sep; 61(3):373-83. PubMed ID: 14066594
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccination of free-living juvenile wild rabbits (Oryctolagus cuniculus) against myxomatosis improved their survival.
    Guitton JS; Devillard S; Guénézan M; Fouchet D; Pontier D; Marchandeau S
    Prev Vet Med; 2008 Apr; 84(1-2):1-10. PubMed ID: 18045714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome sequence of SG33 strain and recombination between wild-type and vaccine myxoma viruses.
    Camus-Bouclainville C; Gretillat M; Py R; Gelfi J; Guérin JL; Bertagnoli S
    Emerg Infect Dis; 2011 Apr; 17(4):633-8. PubMed ID: 21470452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies in the epidemiology of infectious myxomatosis of rabbits. VII. The virulence of strains of myxoma virus recovered from Australian wild rabbits between 1951 and 1959.
    MARSHALL ID; FENNER F
    J Hyg (Lond); 1960 Dec; 58(4):485-8. PubMed ID: 13767209
    [No Abstract]   [Full Text] [Related]  

  • 18. AN ATTENUATED LIVE VIRUS VACCINE FOR MYXOMATOSIS.
    MCKERCHER DG; SAITO JK
    Nature; 1964 May; 202():933-4. PubMed ID: 14190113
    [No Abstract]   [Full Text] [Related]  

  • 19. [Administration of vaccine against myxomatosis using live MXT by means of external ear puncture with a special needle].
    Cupera Z; Krupka V; Jiran E
    Vet Med (Praha); 1982; 27(10):617-26. PubMed ID: 6815860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxomatosis in Australia and Europe: a model for emerging infectious diseases.
    Kerr PJ
    Antiviral Res; 2012 Mar; 93(3):387-415. PubMed ID: 22333483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.